Jeffrey Weisberg
Keine laufenden Positionen mehr
Health Technology
Profil
Jeffrey Weisberg worked as the Chief Medical Officer at Viralytics Pty Ltd.
Ehemalige bekannte Positionen von Jeffrey Weisberg
| Unternehmen | Position | Ende |
|---|---|---|
| VIRALYTICS LTD. | Technik-/Wissenschafts-/F&E-Leiter | 28.02.2013 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Viralytics Pty Ltd.
 Viralytics Pty Ltd. BiotechnologyHealth Technology Viralytics Pty Ltd. engages in the development and commercialization of oncolytic immunotherapies that harness the power of certain viruses to infect and kill cancer cells. Its product, CAVATAK, is a genetically unmodified proprietary formulation of the common cold Coxsackievirus Type A21. The company was founded in 1984 and is headquartered in Sydney, Australia. | Health Technology |
